Match Document Document Title Score
US20150079169 CONTROLLED DOSING OF CLOPIDOGREL WITH GASTRIC ACID INHIBITION THERAPIES  
The present invention provides for novel formulations of clopidogrel in combination with proton pump inhibitors (PPI) and optionally with NSAIDs, for use as improved antiplatelet therapies in...
181
5158765 Hair removal composition  
A depilatory composition for the removal of hair is composed of a mixture of sugar, water and aspirin. This mixture is heated to dissolve the solute materials, and then allowed to cool so as to...
181
6203819 Dietary supplement and method of treatment for diabetic control  
A daily nutritional supplement and method of administering it to assist in the metabolism of glucose for patients with diabetes and pre-diabetes is disclosed. The supplement preferably includes...
180
8889157 Composition for cardiovascular treatment  
A dietary supplement formulation for reducing the risk of coronary heart disease or stroke, and in which there is provided a plurality of vitamins and minerals that together represent a minimum...
175
US20170014432 COMPOSITIONS AND METHODS FOR REDUCING CHRONIC LOW-LEVEL INFLAMMATION  
The invention relates to compositions and methods for reducing chronic low-level inflammation associated with chronic conditions. Specifically, the invention relates to compositions of hydrophobic...
173
US20050215611 Combination therapy for treating cyclooxygenase-2 mediated diseases in patients at risk of thrombotic cardiovascular events  
The present invention encompasses a method for treating a chronic cyclooxygenase-2 mediated disease or condition and reducing the risk of a thrombotic cardiovascular event in a human patient in...
173
US20070202556 METHODS AND KITS FOR DETECTION OF THROMBOXANE A2 METABOLITES  
Methods, compositions and kits are provided for measuring aspirin's anti-thrombotic effectiveness on a subject. Included are a novel assay for quickly and specifically measuring TxA2 metabolite...
172
7041286 Composition for mitigating a pernicious thrombotic event  
A composition. The composition comprises aspirin, magnesium, and nattokinase, and either niacin or nitroglycerine. The composition has a structural form of: a chewable form, a dissolvable form, a...
171
US20110038931 COMPOSITE PREPARATION  
The present invention provides a combination preparation which comprises: a prior-release section comprising aspirin or a pharmaceutically acceptable salt thereof as a pharmacologically active...
169
5981555 Compositions, kits and methods for administration of antilipemic drugs  
The present invention concerns composition, kits and methods for reducing the flushing effect (cutaneous erythema) of an antilipemic drug, for treating hyperlipemia, for improving the...
169
8148416 Treatment of inflammatory, cancer, and thrombosis disorders  
A pharmaceutical composition and a method of treating inflammation in a mammal. The method administers the therapeutic composition to the mammal. The therapeutic composition includes: a standard...
168
US20070298096 Analgesic/Antipyretic Compositions for Enhanced Absorption  
The onset of activity of a first analgesic/antipyretic composition containing an analgesic/antipyretic effective amount of acetaminophen, caffeine and, optionally, aspirin is shortened by...
168
4308251 Controlled release formulations of orally-active medicaments  
An improved tablet formulation is provided comprising an effective amount of an active therapeutic agent, especially an acidic therapeutic agent such as aspirin, a release-controlling agent, and...
167
US20120041915 METHOD FOR DIAGNOSING URTICARIA AND ANGIOEDEMA  
According to the invention there is provided a method for diagnosing urticaria or angioedema including: (a) asking a patient the following questions: are any NSAIDs or aspiring being taken; are...
167
8595165 Method for diagnosing urticaria and angioedema  
According to the invention there is provided a method for diagnosing urticaria or angioedema including: (a) asking a patient the following questions: are any NSAIDs or aspiring being taken; are...
167
7727730 Methods and kits for detection of thromboxane A2 metabolites  
Methods, compositions and kits are provided for measuring aspirin's anti-thrombotic effectiveness on a subject. Included are a novel assay for quickly and specifically measuring TxA2 metabolite...
166
9422701 Toilet water splash inhibiting device  
A toilet water splash inhibiting device for inhibit splashing of toilet water during evacuation of waste into a toilet. The device includes a mixture of liquid body soap, baking soda, vinegar,...
166
US20170174651 Method of Priming Plants Against Abiotic Stress Factors  
A method of reducing cellular damage to a plant by treating the plant with a compound containing an NO-releasing moiety and an H2S-releasing moiety covalently bonded to an aspirin derived core or...
165
2447396 Preparation of stable medicinal salts of acetylsalicylic acid  
The spontaneous hydrolysis of the alkaline and alkaline earth salts of acetylsalicyclic acid, particularly the calcium and magnesium acetylsalicylates ("calcium aspirin" and "magnesium aspirin"),...
164
US20170000771 Thromboxane Receptor Antagonists in AERD/Asthma  
The present invention is directed to methods of treating AERD (aspirin exacerbated respiratory disease) and/or asthma via the administration of a thromboxane receptor antagonist to a patient in...
164
4232012 Composition  
There is described a pharmaceutical composition comprising one or more of 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol; 5-(2-hydroxy-propoxy)-8-propyl-chromone-2-carboxylic acid;...
163
6274170 Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same  
Compounds comprising multi-vitamins, zinc and an anti-platelet aggregating agent for the treatment of atherosclerotic cardiovascular disease (ASCVD) are disclosed. The compounds are provided in...
163
US20060182732 Composition for mitigating a pernicious thrombotic event  
A composition. The composition comprises aspirin, magnesium, and nattokinase, and either niacin or nitroglycerine. The composition has a structural form of: a chewable form, a dissolvable form, a...
162
US20080319068 Novel Polymorph of Acetylsalicylic Acid, and Methods of Making and Using the Same  
A polymer of aspirin is provided by the present invention. Methods of making and using the same are also provided.
161
US20100331285 Novel Polymorph of Acetylsalicylic Acid, and Methods of Making and Using the Same  
A polymorph of aspirin is provided by the present invention. Methods of making and using the same are also provided.
161
US20050019319 Composition for mitigating a pernicious thrombotic event  
A composition. The composition comprises aspirin, magnesium, and nattokinase, and either niacin or nitroglycerine. The composition has a structural form of: a chewable form, a dissolvable form, a...
160
US20160326200 PRODRUG FOR RELEASE OF CISPLATIN AND CYCLOOXYGENASE INHIBITOR  
Pt(IV) prodrugs include one or more conjugated cyclooxygenase inhibitor. Reduction of Pt(IV) to Pt(II) can result cisplatin and a cyclooxygenase inhibitor. For proof of concept, a Pt(IV) prodrug...
160
US20170190726 PRODRUG FOR RELEASE OF CISPLATIN AND CYCLOOXYGENASE INHIBITOR  
Pt(IV) prodrugs include one or more conjugated cyclooxygenase inhibitor. Reduction of Pt(IV) to Pt(II) can result cisplatin and a cyclooxygenase inhibitor. For proof of concept, a Pt(IV) prodrug...
160
7935498 Methods for identifying patients with increased risk of an adverse cardiovascular event  
Methods, compositions and kits are disclosed for identifying patients with an increased risk of experiencing an adverse cardiovascular event where the patient is undergoing aspirin antiplatelet...
160
US20120190655 Intravenous Formulation with Water-Soluble CoCrystals of Acetylsalicylic Acid and Theanine  
An aspirin-theanine cocrystal composition including a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer combined with the quantity of acetylsalicylic acid in a mixture. The...
159
8304404 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine  
An aspirin-theanine cocrystal composition including a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer combined with the quantity of acetylsalicylic acid in a mixture. The...
159
5470876 Topical sod for treating hair loss  
SOD for treating hair loss is disclosed. The SOD has utility in a topical pharmaceutical formulation for the cosmetic treatment of hair loss and the cosmetic stimulation of hair growth. The SOD...
157
4275059 Salicylate anti-inflammatory composition  
The anti-inflammatory activity of aspirin and other salicylate-based, anti-inflammatory drugs is enhanced by administration thereof in conjunction with a phosphonate compound such as EHDP or Cl2 MDP.
155
US20020051814 Composition for the treatment and prevention of ischemic events  
The invention relates to pharmaceutical compositions comprising omeprazole and aspirin wherein the combination is useful for the treatment and prevention of cardiovascular events including heart...
155
6659282 Prevention of neutrophil recruitment  
Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II.
154
US20090036528 Multifunctional and combinational application of aspartame and or futhan  
The present invention is an application, composition, and method of using a pharmaceutically effective amount of aspartame or its primary metabolite aspartyl-phenylalanine in systematic and...
153
5962030 Dietary supplement and method of treatment for diabetic control  
A daily nutritional supplement and method of administering it to assist in the metabolism of glucose for patients with diabetes and pre-diabetes is disclosed. The supplement preferably includes...
153
3946110 Medicinal compositions and methods of preparing the same  
Improvements are set forth in connection with analgesic and antifebritic or antipyretic compositions, tablets with solid medicaments, and methods of preparing such compositions and tablets....
153
6720354 Prevention of neutrophil recruitment  
Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II.
152
6433202 Prevention of neutrophil recruitment  
Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II.
152
10183996 Methods and compositions for treating Siglec-8 associated diseases  
The invention provides methods and compositions for the prevention and treatment of Siglec-8 associated diseases such as chronic rhino sinusitis with concomitant asthma and aspirin-exacerbated...
152
4505862 Diphenydramine dihydrogencitrate  
An analgesic and sleep-aid composition containing an analgesic (e.g. aspirin, APAP or combinations thereof) and diphenhydramine dihydrogencitrate. Discloses several dosage forms including a two...
151
7338971 Treatment of inflammatory, cancer, and thrombosis disorders  
This invention provides for the treatment of inflammatory, cancer and thrombotic disorders through the administration, in combination, of a COX2 inhibitor, low dose aspirin, and antioxidant...
149
US20140220694 METHODS AND COMPOSITIONS RELATING TO PLATELET SENSITIVITY  
The invention identifies and describes proteins that are differentially expressed in platelets resistant to anti-platelet agents such as aspirin (acetylsalicyclic acid) compared to those platelets...
147
7227031 Prevention of neutrophil recruitment  
Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II.
147
7615576 Prevention of neutrophil recruitment  
Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II.
147
7579494 Prevention of neutrophil recruitment  
Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II.
147
US20030125308 Antipruritic agents for external use  
External preparations for treating pruritus containing Aspirin as an active ingredient, which exert an excellent therapeutic effects on pruritus with less side effects.
146
US20090000980 Have-a-heart  
A heart shaped container, designed to attach to your key ring. In the event of a suspected heart attack, a person places his or her thumb under the protruding tab and index finger on the top of...
146
10071981 Method of priming plants against abiotic stress factors  
A method of reducing cellular damage to a plant by treating the plant with a compound containing an NO-releasing moiety and an H2S-releasing moiety covalently bonded to an aspirin derived core or...
146


Search
« search again